Franklin Resources’s Coherus Oncology CHRS Stock Holding History

Franklin Resources’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,000	Closed	-$211K	–	1511
2017 Q4	$211K	Sell	24,000 -1,000	-4%	-$10.7K	﹤0.01%	1479
2017 Q3	$334K	Hold	25,000	–	–	﹤0.01%	1399
2017 Q2	$359K	Hold	25,000	–	–	﹤0.01%	1405
2017 Q1	$529K	Hold	25,000	–	–	﹤0.01%	1379
2016 Q4	$704K	Hold	25,000	–	–	﹤0.01%	1339
2016 Q3	$670K	Hold	25,000	–	–	﹤0.01%	1362
2016 Q2	$422K	Hold	25,000	–	–	﹤0.01%	1407
2016 Q1	$531K	Hold	25,000	–	–	﹤0.01%	1393
2015 Q4	$574K	Hold	25,000	–	–	﹤0.01%	1434
2015 Q3	$501K	Buy	+25,000	New	+$761K	﹤0.01%	1446

Other funds holding CHRS

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Franklin Resources's CHRS Position: Q1 2018 in Review

Franklin Resources sold out of Coherus Oncology (CHRS) in Q1 2018, closing a stake of 24,000 shares — an estimated $211K sold.

Franklin Resources first reported a position in CHRS in Q3 2015 and held it in 10 quarters. The position peaked at $704K in Q4 2016. 103 funds tracked by Wall St. Rank hold CHRS as of Q1 2018.

Franklin Resources reported no remaining Coherus Oncology position as of Q1 2018 after selling out during the quarter.
Franklin Resources sold 24,000 Coherus Oncology shares in Q1 2018, an estimated $211K.
Franklin Resources first reported a position in Coherus Oncology in Q3 2015 and held it in 10 quarters.
Franklin Resources's Coherus Oncology position peaked at $704K in Q4 2016.
103 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2018.

Based on Franklin Resources's 13F filing for Q1 2018, filed 10 May 2018.